Form 4 for TBPH Theravance Biopharma, Inc.
Accepted 2025-02-24 00:00:00 ET · period of report 2025-02-10 · accession 0001415889-25-005347 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-24 | 2025-02-20 | TBPH | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | F - Tax | $9.66 | -15.8K | 299.0K | -5% | -$152.7K | |
| 2025-02-24 | 2025-02-10 | TBPH | Farnum Rhonda | SVP, COMM, MEDICAL AFFAIRS | A - Grant | $0.00 | +5,283 | 314.8K | +2% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-02-20 | F | D | 15,810 | $9.66 | 299,038 | D | — | — | (F2) Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction. |
| 2 | Common | Ordinary Shares | 2025-02-10 | A | A | 5,283 | $0.00 | 314,848 | D | — | — | (F1) On April 2, 2024 the reporting person was granted a performance restricted stock unit award that vests based on the achievement of certain performance conditions and continued employment. On February 10, 2025, the performance conditions were deemed achieved as to 5,283 RSUs, and such RSUs became eligible to vest based on the reporting person's continued service. |